MEDX Holdings
Horizon Kinetics Medical ETF
1W: -2.8%
1M: -6.8%
3M: -6.9%
YTD: +4.4%
1Y: +9.8%
3Y: +26.0%
$34.66
-0.14 (-0.41%)
Weekly Expected Move ±2.4%
$33
$34
$35
$36
$36
Overview
Chart
Holdings
Changes
Technicals
Analysis
Peers
Institutions
Dark Pool
Short Interest
Dividends
Weather
ETF-Level Metrics
AUM$19M
Holdings31
Top 10 Wt67.2%
Beta0.52
% Profitable44%
Coverage92%
Portfolio Valuation
P/E37.1
P/B14.1
P/S7.9
EV/EBITDA22.5
P/FCF33.0
PEG2.29
Profitability & Returns
Gross Margin77.3%
Net Margin21.3%
ROE40.6%
ROA11.1%
ROIC22.6%
Div Yield1.70%
Leverage & Liquidity
Debt/Equity1.39
Debt/Assets0.39
Net Debt/EBITDA1.7x
Interest Cov12.9x
Current Ratio1.18
Quick Ratio0.91
Growth (YoY)
Revenue+19.3%
Net Income+28.0%
EPS+35.3%
FCF+46.4%
EBITDA+35.9%
Rev CAGR 3Y+12.9%
Quality Scores
Piotroski F6.5
Altman Z3.44
IS Quality71.6
IS Overall61.3
IS Value40.8
Median P/E16.2
Sector Breakdown
2 sectors| Sector | # Holdings | Total Weight % | Avg P/E |
|---|---|---|---|
| Healthcare | 31 | 91.6% | 18.2 |
| Other | 3 | 8.4% | — |
Smart Money Overlap
3 holdings with signals
Showing 34 of 34 holdings
· Page 1 of 1
| # | Name | Ticker | Weight % ▼ | Mkt Value | Shares | P/E | Mkt Cap | Sector |
|---|---|---|---|---|---|---|---|---|
| 1 | Eli Lilly & Co | LLY | 18.58% | $3.1M | 2,654 | 38.2 | $1.1T | Healthcare |
| 2 | AbbVie Inc | ABBV | 9.60% | $1.6M | 6,068 | 74.0 | $464.3B | Healthcare |
| 3 | US BANK MMDA - USBGFS 7 06/01/2031 Private | — | 8.27% | $1.4M | 1,366,806 | — | — | — |
| 4 | Novartis AG | NVS | 6.54% | $1.1M | 7,582 | 21.3 | $268.0B | Healthcare |
| 5 | Johnson & Johnson | JNJ | 6.08% | $1.0M | 3,798 | 29.6 | $617.0B | Healthcare |
| 6 | Amgen Inc | AMGN | 4.75% | $785,695 | 1,864 | 24.8 | $217.5B | Healthcare |
| 7 | Merck & Co Inc | MRK | 4.67% | $771,305 | 5,308 | 114.5 | $356.4B | Healthcare |
| 8 | Bristol-Myers Squibb Co | BMY | 4.51% | $744,806 | 11,936 | 13.5 | $124.9B | Healthcare |
| 9 | Alkermes PLC | ALKS | 4.46% | $737,383 | 18,198 | 103.6 | $7.0B | Healthcare |
| 10 | AstraZeneca PLC | AZN | 4.43% | $731,944 | 4,533 | 23.4 | $243.3B | Healthcare |
| 11 | Pfizer Inc | PFE | 3.53% | $583,861 | 20,472 | 36.7 | $158.4B | Healthcare |
| 12 | Biogen Inc | BIIB | 3.37% | $556,568 | 2,464 | 38.7 | $32.5B | Healthcare |
| 13 | Alnylam Pharmaceuticals Inc | ALNY | 2.93% | $483,610 | 1,960 | 36.0 | $29.4B | Healthcare |
| 14 | CRISPR Therapeutics AG | CRSP | 2.79% | $461,479 | 8,342 | -11.6 | $5.3B | Healthcare |
| 15 | Ionis Pharmaceuticals Inc | IONS | 2.66% | $440,070 | 9,856 | -12.6 | $7.2B | Healthcare |
| 16 | Regeneron Pharmaceuticals Inc | REGN | 2.61% | $432,214 | 570 | 17.6 | $75.7B | Healthcare |
| 17 | GSK PLC | GSK | 2.59% | $428,713 | 8,900 | 14.8 | $94.2B | Healthcare |
| 18 | Beam Therapeutics Inc | BEAM | 1.12% | $185,380 | 7,582 | -29.9 | $2.5B | Healthcare |
| 19 | Galectin Therapeutics Inc | GALT | 1.00% | $164,714 | 42,452 | -9.1 | $257M | Healthcare |
| 20 | Replimune Group Inc | REPL | 0.91% | $150,592 | 11,374 | -4.1 | $1.1B | Healthcare |
| 21 | Intellia Therapeutics Inc | NTLA | 0.83% | $137,170 | 11,374 | -3.6 | $1.7B | Healthcare |
| 22 | Sandoz Group AG | SDZNY | 0.78% | $128,516 | 1,520 | 55.5 | $35.9B | Healthcare |
| 23 | Haleon PLC | HLN | 0.61% | $100,143 | 11,127 | 18.1 | $38.8B | Healthcare |
| 24 | Vanda Pharmaceuticals Inc | VNDA | 0.61% | $100,518 | 20,472 | -1.0 | $278M | Healthcare |
| 25 | Editas Medicine Inc | EDIT | 0.39% | $64,301 | 25,020 | -3.5 | $402M | Healthcare |
| 26 | GE HealthCare Technologies Inc | GEHC | 0.30% | $49,681 | 760 | 18.5 | $29.0B | Healthcare |
| 27 | Viatris Inc | VTRS | 0.30% | $50,006 | 2,822 | -48.9 | $20.5B | Healthcare |
| 28 | Bicycle Therapeutics PLC | BCYC | 0.25% | $41,856 | 11,374 | -1.2 | $235M | Healthcare |
| 29 | Allogene Therapeutics Inc | ALLO | 0.15% | $24,262 | 15,164 | -2.2 | $518M | Healthcare |
| 30 | Lantern Pharma Inc | LTRN | 0.14% | $22,973 | 22,746 | -0.5 | $11M | Healthcare |
| 31 | Pacific Biosciences of California Inc | PACB | 0.13% | $21,567 | 9,100 | -5.9 | $789M | Healthcare |
| 32 | Cash & Other Cash | — | 0.12% | $19,439 | 19,439 | — | — | — |
| 33 | Decoy Therapeutics Inc | DCOY | —% | $39 | 20 | — | — | Healthcare |
| 34 | Pathos AI Inc Private | — | —% | — | 23,992 | — | — | — |